A European consortium, led by the LUMC, has received a Horizon Europe grant of 6 million euros to develop an app that makes stopping anticoagulation during the last phase of life a topic of discussion for doctors and patients.
Anticoagulation is rarely discontinued during the last phase of life. This is due to a lack of scientific evidence, but also because there is too little talk about death and death by the treating physician and the patient.
Professor Erik Klok, co-initiator Prof. Simon Noble from Cardiff and European colleagues hope to stimulate discussion about this with an online app. The application initiates the conversation between doctor and patient through questions. It also estimates the individual risk of bleeding and thrombosis.
The first two years of the SERENITY project will be devoted to epidemiological and qualitative research, consensus building and app development. After that, the app is tested in practice. The app is expected to lead to less bleeding and significant cost savings. But also to improve the quality of life and treatment satisfaction of patients, their carers and the healthcare workers involved.
Bron:
–
